Cardiogenic Shock by Leitch, Andrew Gordon
80% of people developing shock after 
myocardial infarction die. This essay is con- 
cerned to ask why they die and what can be done 
about it. 
Accordingly it consists of two parts: 
the one concerned with the definition and some 
relevant aspects of the pathogenesis of cardio- 
genic shock; the other concerned with therapy, 
its difficulties and its future. 
CARDIOGENIC SHOCK 
1. DEFINITION AND PATHOGENESIS 
Cardiogenic shock is shock occurring after myocardial 
infarction. It has been variously described as occurring 
in 6% (32), 8% (50) (63), 10% (88) (113), 12% (136) and 20% 
(52) of patients with myocardial infarction. Shock accom- 
panies the onset of pain in few cases (32) and most cases 
occur in the first twenty -four hours after infarction (32) 
(113) although they may occur several days after (63). 
The criteria for diagnosis of shock may vary with 
different authors (hence the anomalous 20% above) but, in 
general, it is agreed (32) (46) (50) (55) (61) (96) (148) 
that shock is suggested clinically by the following features: 
cold, clammy extremities, pallor and cyanosis, rapid, thready 
pulse, anuria or oliguria, anxiety, restlessness or apathy, 
and prolonged hypotension. The only objective assessment is 
of blood pressure and this alone does not define shock (148). 
Considerable variation may therefore be expected in diagnosis. 
In view of the difficulties in defining the criteria for 
diagnosis of shock, the individual criteria and the inter- 
pretations placed upon them warrant further discussion. 
The pallor, coldness, clamminess and oliguria are taken 
to indicate an increase in activity of the sympathetic nervous 
system leading to sweating and a reduction in blood flow to 
the skin and the kidney respectively. Similarly, signs of 
anxiety, restlessness or apathy are taken to indicate a re- 
duction in cerebral blood flow or cerebral hypoxia. Anxiety 
or restlessness might be expected in patients who are in pain 
and apprehensive of their mortal future. Adequate methods 
for/ 
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for the measurement of arm (20) and cerebral blood flow (62) 
exist but the measurements do not yet appear to have been 
made in cardiogenic shock. The tachycardia also reflects 
the increased activity of the sympatho- adrenal system, the 
increased rate being due probably to an increase in sympathetic 
activity to the heart and to the high level of blood cate- 
cholamines in shock (158). The increase in urinary nora- 
drenaline and adrenaline which has been demonstrated after 
myocardial infarction appears to be related to the clinical 
severity of the condition (158). The thready pulse may be 
taken as an indication of the reduction in stroke volume (96). 
Cyanosis represents an increase in the amount of reduced 
haemoglobin visible in the sub -papillary venous plexuses (94) 
and is influenced by the haemoglobin content of the blood. 
So- called central cyanosis is said (46) to represent an 
arterial oxygen saturation of less than 90 - 95% but trained 
clinical observers are unanimous in their observation only 
when the oxygen saturation of blood is as low as 75% (106). 
The misleading effects of fluorescent lighting are important 
(79). Such cyanosis may be due to inadequate pulmonary 
oxygenation, increased deoxygenation of arterial blood or 
veno- arterial shunts. All three may be important in cardio- 
genic shock (see later). 
Hypotension is difficult to define in view of the wide 
range of normal blood pressures in the general population 
(58) (111). Indirect measurement of brachial systolic blood 
pressure with a sphygmomanometer compares favourably with 
direct intra- arterial recording (at least at normal levels 
of blood pressure) within certain limitations, e.g., cuff 
width/ 
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width and length (15) (57) (58) (77) (121) (124) (138). 
Whether the agreement is of the same order in hypotension is 
not recorded. A systolic blood pressure of less than 
100 mm.Hg. (96) or less than 90 mm.Hg. (111) has been taken 
as indicating shock while others feel that a systolic blood 
pressure of less than 80 mm.Hg. is a necessary criterion of 
shock (32) (50) (53) (141). Others again adhere to 80 mm.Hg. 
with an "allowance" of 90 (63) or 100 mm.Hg. (52) for prev- 
iously hypertensive patients. Mutual agreement about the 
value of blood pressure taken to indicate shock is desirable 
if therapeutic trials are to be comparable. Hypotension in 
shock can be taken to indicate that the heart is unable to 
maintain blood pressure by an adequate output in a situation 
where the total peripheral resistance is normal or raised 
(53) (96) (151) (152). It must be distinguished from the 
initial hypotension often seen in myocardial infarction which 
is relieved by analgesics or sedatives and is attributed to 
pain (46). Vaso -vagal attacks (5) (153) and excessive doses 
of morphine, pethidine or sedatives (46) may also be mislead- 
ing causes of hypotension. 
The clinical definition of shock is not entirely satis- 
factory and since the early classical studies of Coumand (31) 
attempts have been made to find a haemodynamic expression of 
shock. Right heart catheterisation is essential in haemo- 
dynamic studies if one is to measure cardiac output, central 
venous pressure and pulmonary artery pressure. It is used 
for withdrawing samples of "mixed" venous blood for direct 
Fick or injecting dye for dye diffusion estimations of cardiac 
output (59) (147) (160). Cardiac output is traditionally 
expressed/ 
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expressed as cardiac index (L /min. /m2) (161) in an attempt 
to eliminate variations in cardiac output related to body 
size. The total peripheral resistance can be calculated 
from the relation 
CARDIAC INDEX = 
MEAN AORTIC PRESSURE - CENTRAL VENOUS PRESSURE 
TOTAL PERIPHERAL RESISTANCE 
In animals the haemodynamic consequences of shock have 
also been studied after coronary embolisation with spores 
or microspheres (1) (12) (90), coronary ligation (28) (47) 
or occlusion (120). 
The outstanding feature of haemodynamic studies has been 
the uniform demonstration of a fall in cardiac index in 
cardiogenic shock (148) (162). It is important to remember 
that this is an acute fall in cardiac index. In general, 
the lower the cardiac index, the more severely ill the patient 
is, although specific instances have recently been described 
(151) (152) where a very low cardiac index has been present 
in patients without shock. Hypotension itself is not 
sufficient to define shock since sympathectomised patients 
may have adequate tissue perfusion with a slow pulse and a 
low blood pressure (148). The effect of fever on the total 
peripheral resistance may cause a similar phenomenon (103). 
Although reduction of cardiac index may be present in non - 
shocked patients, severe reduction of stroke volume seems 
to be more "specific" to cardiogenic shock (96) and coupled 
with the demonstration of an increased cardiopulmonary blood 
volume indicates failure of the left ventricle as a pump. 
Total peripheral resistance in shock has been described 
as being increased (53) (96), normal (53) (96), or decreased 
(53)/ 
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(53) (55). Gunnar (53) (55) divides his cases into two 
groups: one with an increased peripheral resistance which 
is considered to represent the normal reflex response to a 
fall in cardiac index and one with a decreased peripheral 
resistance which is believed to be the result of some vas- 
cular reflex from the damaged heart. Patients with a low 
total peripheral resistance responded to noradrenaline by 
increasing peripheral resistance which is taken to indicate 
that the vasoconstrictor mechanism is still functional al- 
though reflex vasoconstriction is inhibited by a reflex from 
the damaged heart. However, in cats the vascular tree can 
be responsive to noradrenaline in the "shock state" long 
after it has ceased to respond to sympathetic nerve stimul- 
ation (89) (107). 
The heart has many receptors (64). Stimulation of some 
of them may lead to hypotension as, for example, in the left 
ventricular Bezold -Jarisch reflex (64) (118) with veratrine. 
This may be the mechanism of the bradycardia and hypotension 
seen in "shocked" dogs (29) which is abolished by vagotomy. 
Possible receptors for such a reflex have been described 
(139). Agress (1) has described another possible reflex in 
dogs mediated by the dorsal sympathetic roots, but his 
attempts to identify and block such a reflex in man have not 
been continued and were presumably unsuccessful. The higher 
frequency of shock in patients with branch rather than main 
stem occlusions in the coronary arteries has been given as 
a possible indication of reflex mechanisms in human cardio- 
genic shock (86). However, the significance of a reflex 
from the injured myocardium remains undetermined. Dogs 
with/ 
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with denervated hearts may still be shocked after infarction. 
Presumably people with transplanted hearts will still be 
liable to develop shock after myocardial infarction. This 
and the slow onset of shock (32) (113) do not favour a re- 
flex mechanism. 
An acute fall in cardiac index is the basic lesion in 
cardiogenic shock. Shock is not associated with any par- 
ticular size (32) or site (113) of infarction. In one study 
shocked patients had a higher incidence of previous infarction 
than non- shocked patients (113) whereas the post -mortem hearts 
examined by Cronin (32) indicated that shock cases had a lower 
incidence of previous infarction. 
previous infarct might protect the 
ment of significant inter -coronary 
Cronin suggests that a 
heart through the develop - 
anastomoses (126). The 
impairment of cardiac function has been briefly described by 
MacKenzie et al (96). In their study measurements of myo- 
cardial performance indicated "gross impairment" in cardio- 
genic shock. 
MacKenzie's fuller and more important studies in the 
same paper demonstrated that in shocked patients the Pa02 was 
very low (mean 47 mm.Hg.) compared with non -shocked patients 
(mean 67 mm.Hg.) and that whereas Pa02 rose to expected levels 
(mean 391 mm.Hg.) on administration of 87% oxygen to non- 
shocked patients, in shocked patients with oxygen the Pa02 
still remained remarkably low (mean 119 mm.Hg.). This has 
since been described by others (101) (117). A markedly in- 
creased alveolar -arterial oxygen tension gradient was also 
described (96) and has been confirmed by others in cardiogenic 
shock (100) (101) and in acute myocardial infarction without 
shock/ 
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shock (65) (117) (157). A significantly increased gradient 
is present even six to twelve months after infarction (102). 
The hypoxaemia is not due to inadequate ventilation since 
the PaCO2 is normal or even decreased in these cases (96) 
(101). The hypoxaemia is due partly to an increased physio- 
logical dead space (65) (101) (117); partly to venous ad- 
mixture (101) (117) (157) and also in some patients to the 
presence of a true shunt (96) (117) (164). The disturbed 
ventilation- perfusion ratios are probably due, in part, to 
the fall in cardiac index observed in shock leading to per- 
fusion changes, and, in part, to the increased pulmonary 
venous pressure accompanying pump failure (101) leading to 
pulmonary congestion (87). The rise in left ventricular 
end -diastolic pressure which is implied in the genesis of 
pulmonary congestion and oedema in cardiogenic shock has 
recently been demonstrated (82). Detailed investigation of 
the ventilation -perfusion ratio changes in different parts 
of the lung should be possible with the techniques which have 
been described (30), but investigations of this nature have 
yet to be carried out in cardiogenic shock. They should 
demonstrate more clearly the nature of the ventilation per- 
fusion imbalance. 
The presence of pulmonary congestion in cardiogenic 
shock probably depends partly on the enthusiasm with which 
it is sought and partly on the severity of the cases described. 
For example, Cronin found crepitations absent in most of his 
140 cases (32) while Nielsen describes frank pulmonary oedema 
necessitating treatment with digitalis in 309.; of his 34 cases 
(113). McNicol (101) basing his diagnosis of congestion on 
the/ 
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the presence of crepitations or rhonchi in the absence of 
a history of bronchitis found pulmonary congestion in 13 
out of 15 shocked patients. Radiological criteria are 
also valuable (157). McNicol has demonstrated unequivocally 
the importance of congestion in the genesis of hypoxaemia 
after acute myocardial infarction. Two of his shock cases 
had no clinical evidence of congestion and itis suggested 
that in these cases the hypoxaemia is due solely to a gross 
disturbance of perfusion. Indeed, an increased physio- 
logical dead space was very evident in these patients. It 
is in such cases particularly that a regional analysis of 
ventilation -perfusion ratios would prove interesting. 
The true shunt which has been described is thought un- 
likely to be due to arterio- venous anastomoses "since it 
disappeared on recovery in two cases" (96). The possibility 
of arterio- venous anastomoses as a factor in shunt at high 
altitude has been described in association with an elevated 
pulmonary arterial pressure (125) but no such relationship 
between presence of shunt and pulmonary arterial pressure 
exists after myocardial infarction (59). It has been 
suggested that the shunt may be due to "collapse, oedema or 
blockage of alveoli in some areas of the lung where there is 
continued circulation." (96). This is more likely. 
The hypoxaemia of cardiogenic shock is associated with 
a significant acidosis (96) (97) due principally to a rise 
in the concentration of blood lactate. Kirby and McNicol 
(81) note that the acidosis found in acute myocardial in- 
farction is most severe in patients with hypotension 
(4;90 mm.Hg.) plus left ventricular failure (? shocked). 
The/ 
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The demonstrated rise in lactate /pyruvate ratio (96) is 
indicative of tissue hypoxia (114a) and reflects an increase 
in the oxidation of NADH2 by the conversion of pyruvate to 
lactate in the cycle of anaerobic glycolysis. Anaerobic 
glycolysis is more active in hypoxia because less molecular 
oxygen is available for the operation of the cytochrome 
system and aerobic glycolysis. 
The increased mortality found with severe acidosis is 
probably causally related and represents an association 
between two accompaniments of tissue hypoxia. In man 
correction of the acidosis leads to an increase in blood 
pressure in non -shocked patients (111) but this may have 
been related to the procedure and to the volume infused. 
The effect of correction in shocked patients is not document- 
ed. Other reports associate acidosis with arrhythmias in 
man (119), decreased myocardial contractility in dogs (25) 
(42), and vasopressor antagonism in dogs (155). In dogs 
the combination of acidosis and hypoxaemia is particularly 
lethal (104);the survival rate is increased by correction of 
both. 
The following functional points are also worthy of note. 
The hypotension of shock will lead, to a significant reduction 
in coronary blood flow since in the human case of infarction 
(but not the dog (123) and hence partly the dubious rele- 
vancy of experimental cardiogenic shock in dogs) the coronary 
vessels will almost certainly be atherosclerotic, arterio- 
sclerotic or even calcified. This will limit or even elim- 
inate any faculty for vasodilatation in response to hormonal, 
nervous, metabolic or any other demands. In this situation 
the/ 
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the coronary flow becomes to a greater or lesser extent 
dependent on aortic diastolic pressure (54) (63) (127) 
since most coronary flow occurs during diastole. The 
existence of coronary autoregulation is still debated (7) 
but where demonstrated it probably ceases, like cerebral 
autoregulation, at pressures of 50 -80 mm.Hg. The effect 
of degenerative arterial disease on coronary autoregulation 
is not known and it should be possible to study this in a 
suitable animal preparation with and without the complica- 
tions of myocardial infarction since its effect can only be 
guessed in man. Arterial disease is found in a wide range 
of animals including snakes, lizards, tortoises and vultures 
(44). Disease can also be produced by altering the diet 
of rabbits, rats (78) and pigs (73) and this disease closely 
resembles that found in man. The effect of coronary artery 
disease on autoregulation of coronary blood flow would be 
most easily studied in the pig. (For similar reasons the 
pig would seem to be a more suitable animal than the dog 
for investigating the efficacy of different forms of therapy 
in cardiogenic shock). For the moment it is agreed em- 
pirically that a pressure of 50 -80 mm.Hg. is usually adequate 
to maintain coronary and cerebral blood flow. Regional 
flow studies (62) (160) might be interesting here also. In 
view of the need for a minimum blood pressure difficulties 
arise in therapy (see later) since attempts to increase the 
aortic pressure by vasoconstriction to maintain coronary 
flow will increase the afterload of an already embarrassed 
heart (16). 
The sympathetic vasoconstriction observed in shock leads 
to/ 
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to a reduction in renal blood flow, glomerular filtration 
rate and urine secretion (156). If this oliguria (or 
anuria) is maintained microscopic changes may be visible 
in the kidney structure (148). Similarly impairment of 
liver function has been demonstrated in acute myocardial 
infarction (21) which is probably related to hepatic vaso- 
constriction (43). This may be a factor in the lactic 
acidaemia. 
The changes observed in the peripheral circulation in 
shock have been investigated by many workers (112). Micro- 
scopic examination of the microcirculation in shocked animal 
preparations (112) (165) has shown great species variation 
in the behaviour of the microcirculation during shock and 
it is difficult from the observations which have been made 
to indicate any consistent microcirculatory defect in shock. 
However, disturbances of vasomotion and of the flow patterns 
in exchange vessels (6) have been observed. The role of 
arterio- venous shunts in the microcirculation remains un- 
certain (112). 
Coupled with disturbances of flow, pressure and exchange 
relationships in the microcirculation may be disturbances of 
the coagulation mechanism (61) which have been observed in 
shocked patients by the proponents of a hypothetical mechan- 
ism for disseminated intravascular coagulation (60) (61) or 
sludging (85). This will lead to further disturbance of 
the exchange and nutritive functions of the microcirculation. 
If present in cardiogenic shock sludging should be visible 
in the bulbar conjunctiva (85) (92). 
Mellander (89) (107) using his technique for the indirect 
study/ 
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study of the microcirulation in cat skeletal muscle (Figure 
1)* has noticed in shock a progressive decline in the pre - 
capillary resistance response to sympathetic nerve stimula- 
tion while the capacitance response remains (Figures 1 and 2) *. 
However, unphysiological doses of noradrenaline will retrieve 
the resistance response when sympathetic nerve stimulation 
fails (Figure 1:Q) *. If shock is prolonged the capacitance 
response to sympathetic nerve stimulation is abolished and 
intravascular pooling may occur. At the same time dis- 
turbances of the relationship between pre- and post -capillary 
resistances and hence the Starling mechanism (146) will lead 
to haemoconcentration. Mellander interpreted the refractori- 
ness to sympathetic nerve stimulation as being due to the 
presence of tissue hypoxia and accumulated "metabolites ". 
The nature of such metabolites remains uncertain but acidosis 
is probably a factor (155). 
Cat skeletal muscle in haemorrhagic shock is not the 
human peripheral circulation in cardiogenic shock but com- 
parisons are useful and apparently valid since recent pub- 
lications (14) (90) allow the following tentative interpre- 
tation of peripheral circulatory failure in cardiogenic shock: 
after infarction cardiac function is severely impaired (96) 
and although increased sympatho- adrenal activity may be 
adequate at first to maintain blood pressure it is later in- 
adequate (89) (107). If the vasoconstriction is severe or 
prolonged enough it leads to tissue hypoxia (45) and acidosis 
(81). Hypoxaemia (96) will exaggerate this phenomenon and 
total peripheral resistance may fall. Progressively the 
resistance vessels become refractory to sympathetic nervous 
stimuli/ 
*See Appendix for Figures 
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stimuli (107) while maintaining some sensitivity to nor - 
adrenaline. Ultimately this response also disappears (63) 
(113) along with the capacitance response. This may lead 
to acidosis, loss of capillary integrity, haemoconcentration, 
stagnation, disruption of lysosomes (14), coagulation of 
blood (61) and tissue destruction with consequent loss of 
organ function and death. Prominent among the ultra - 
structural changes in shock is mitochondrial damage (67). 
The role of the sympatho- adrenal system in this sequence 
of events is prominent enough to make one wonder what the 
effect of coronary embolisation or ligation might be in dogs 
or other animals which had either been sympathectomised or 
made tolerant of catecholamines. Would the same percentage 
of sympathectomised or catecholamine -tolerant dogs develop 
shock as compared with normal animals?. If so, would the 
mortality be altered? Would chemical sympathectomy show 
the same effect? If the effect was beneficial might it be 
applicable to human cases as a form of "preventive" treatment 
for cardiogenic shock? Do people who have been sympathec- 
tomised develop cardiogenic shock as often as the rest of the 
population? If so, do they also have an 80% mortality? 
The sequence of events in shock is never seen in its 
undisturbed entirety since therapy is usually instituted 
early in the march of events and may modify the picture con- 
siderably. However, it obviously fails to alter the picture 
enough since the mortality remains at 800 (32) (50) (88) (127). 
More optimistic figures for mortality (52) are misleading and 
probably reflect the inclusion in the diagnosis of shock of 
patients with the brief initial hypotension often seen after 
myocardial/ 
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myocardial infarction (46). 
11. THERAPY 
The logic behind the therapy of cardiogenic shock is 
simple - the application less so. Basically it consists 
of trying to keep the patient alive until his heart has 
healed enough to function adequately. In an unknown per- 
centage of patients this will never happen regardless of 
therapy short of total replacement. 
There was a time when the object of therapy was to keep 
the blood pressures at normal levels with vasoconstrictors 
(70). More recently, however, it has been accepted that to 
prevent the development of tissue hypoxia with its attendant 
fatal complications (14) it is desirable to think not only in 
terms of increasing cardiac index but also of protecting the 
periphery from the ravages of vasoconstriction. 
Much of the therapy which will be described may require 
more facilities than the still all too rare coronary care 
unit (50) (88) (115) (154) can provide and is certainly as 
yet far removed from simple ward therapy. Facilities for 
cardiac catheterisation, monitoring pressures etc. (136) 
(151) are still limited principally to research investigations 
and provide useful information on the effectiveness of 
different therapies. In view of the high mortality of shock 
cases, even with intensive therapy, it would seem reasonable 
that they should not occupy intensive care beds to the ex- 
clusion of other patients who might more obviously benefit 
from the advantages offered by such a unit. 
Dog experiments have been used as "therapeutic trials" 
in cardiogenic shock and it is worth recalling that dogs with 
experimental/ 
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experimental acute myocardial infarction (51) (in common with 
many surgical patients with low output shock (12))are suffer- 
ing from a condition that is superimposed on an otherwise 
healthy heart and not one with diseased arteries and the con- 
sequences of progressive ischaemia over the years. Dog ex- 
periments should therefore not give rise to false hope. 
It is proposed to discuss those aspects of therapy which 
the present author finds most relevant or interesting. The 
author feels justified in looking to the future in his con- 
sideration of therapy. Indeed, the present status of therapy 
renders such an attitude essential. 
Initial Therapy 
In cardiogenic shock the importance of immediate therapy 
has long been realised (52) (63). Patients should be put to 
bed supine unless the complications of pulmonary oedema have 
arisen. There is some dispute as to the incidence of this 
complication in cardiogenic shock but if diagnosed it should 
be treated in accordance with its severity (46). If admin- 
istration of pethidine or morphine is needed to relieve pain 
then the dosage should not be excessive since both drugs 
have hypotensive and respiratory depressant effects (72) 
(133) (150). Shock patients are more liable to arrhythmias 
and asystoles ( a reflection of the hypoxic state ?) than 
patients with uncomplicated infarction (50) (80). These 
should be treated according to standard therapy (46) ( ?5) 
(133) (136). If acidosis is present this should be corrected 
by the administration of bicarbonate or TRAM (in that order 
of preference): this in itself may reverse arrhythmias (119). 
Oxygen should be administered immediately. 
Oxygen / 
- 16 - 
Oxygen 
The administration of oxygen in cardiogenic shock has 
a sound theoretical basis (45) - the rationale being that 
the tissue Po 
2 
should be of the order of 10 mm.Hg. for 
metabolism to function aerobically. In cardiogenic shock 
the tissue Po 
2 
is probably much lower (45). Pa02 in shock 
is low (96). Pa CO2 being essentially normal, adminis- 
tration of 100% oxygen is preferred (98) since the Pa02 of 
some patients may be refractory to oxygen therapy (96) (101) 
(117). In acute myocardial infarction (149) and in cardio- 
genic shock (96) oxygen leads to no significant change in 
heart rate, asmall fall in cardiac index and a slight rise 
in total peripheral resistance. Pa02 will rise, the oxygen 
diffusion gradient will increase and there will be a slight 
increase in the amount of oxygen carried by the blood. In 
cardiogenic shock the blood should carry as much oxygen as 
possible (45) (77). With this in mind the possibility of 
hyperbaric oxygen therapy will be considered later. 
"Traditionally" the next step has been to elevate the 
blood pressure with vasoconstrictors. 
Vasoconstrictors 
The importance of elevating blood pressure to a certain 
minimal level in order to maintain satisfactory coronary and 
cerebral blood flow has already been mentioned. Certain 
agents e.g., angiotensin have no place in this sort of therapy 
(136) since they act solely on the peripheral circulation and 
increase total peripheral resistance and blood pressure at 
the expense of increasing cardiac overload and decreasing 
cardiac index. In a situation where cardiac index is already 
too/ 
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too low a further decrease is not recommended. Similar 
arguments apply to purely 0Cadrenergic agents (95) (136). 
At this point it is convenient to mention that the termin- 
ology applied to the sympathomimetic drugs in this essay is 
that of Ahlquist (2). In his terminology Y drugs are drugs 
which act on receptors and are associated with vaso- 
constriction while J drugs act on J receptors and are 
associated with vasodilatation and myocardial stimulation. 
drugs combine both these actions. 
04 3 drugs such as noradrenaline and metaraminol (which 
releases noradrenaline from tissue stores (14)) have been 
used in classical therapy for some years, Both drugs act 
in small doses to increase myocardial contractility (131) 
and in larger doses to vasoconstrict all regional circulations 
except the coronary (66). Their pressor effect is pre- 
dominantly due to the vasoconstriction and their action pro- 
vides a high pressure -low flow system since the vasoconstric- 
tion decreases peripheral flow and the elevation in pressure 
increases cardiac work and hence decreases cardiac index (66) 
(87) (127) (133) (136) (141). Only in small doses will nor - 
adrenaline elevate the cardiac output. Difficulty is en- 
countered in trying to weigh the merits of high pressure in 
increasing coronary flow against the disadvantages of in- 
creasing heart pressure work (66). In general, the use of 
sympathomimetic amines in cardiogenic shock is of dubious 
value and since they have been shown to cause shock in man 
(117) and dog (43) provides an interesting paradox. 
There is no convincing demonstration in the literature 
that noradrenaline therapy has significantly affected the 
mortality/ 
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mortality from cardiogenic shock, indeed one trial hinted 
that the drug might have an adverse effect on the outcome 
of shock (132). No effect of noradrenaline therapy on 
mortality is seen in Cronin's 140 cases (32). Earlier 
reports of a halving of mortality (52) (63) have not been 
borne out and the patient ssL ction procedure allows of the 
possibility that some non- shocked patients were included in 
these series. Gunnar, with his original interpretation of 
the pathogenesis of cardiogenic shock, is a stout upholder 
of noradrenaline therapy. Nevertheless, of his patients 
(53) (55) 65% died from shock and another 25% died shortly 
after recovering from shock. 
Friedberg's recent statement that a pressor effect with 
noradrenaline is obtained in 80 - 90i6 of cases (46) must be 
with figures (113) show 
of patients are refractory to vasoconstrictors. The differ- 
ence probably lies in the stage of shock at which treatment 
was initiated since refractoriness to noradrenaline is one of 
the later manifestations of shock and reflects the beginning 
of some of the more severe microcirculatory changes (14) (95) 
(107). This refractory state is almost invariably fatal (63). 
Prolonged use of vasoconstrictor drugs may lead to an 
exaggeration of tissue hypoxia and the associated metabolic 
changes and ultimately to "decompensation" or reversal of the 
Starling mechanism (146) which causes net movement of fluid 
into the circulation in shock. In this state fluid may leave 
the circulation and haemoconcentration may occur. De- 
compensation is accelerated by noradrenaline and delayed by 
adrenergic blocking drugs. 
Dog/ 
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Dog experiments have recently demonstrated that nor- 
adrenaline therapy alone in experimental cardiogenic shock 
does not significantly alter the mortality from the control 
value in untreated dogs (12) (35). Other therapy in dogs is 
more encouraging (see later). 
The value of noradrenaline is limited only to the 
inotropic effect observed with small doses. This is almost 
certainly useful in some cases and in order to be of most 
value the vasoconstrictor effect should be minimised as much 
as possible. 
Acceptance of the general failure of noradrenaline therapy 
is not yet complete. However, as an alternative to the high 
pressure -low flow system achieved with noradrenaline, it would 
seem that a low pressure -high flow system might be more 
in preventing 
To this end the possibility of therapy with /3 drugs and oc 
blocking drugs will now be discussed. The difficulty with 
this sort of therapy is going to be in deciding what minimum 
pressure is acceptable to the system and whether at this 
pressure the heart can function adequately enough to maintain 
the required flow. 
i Adrenergic Drugs 
The use of isoprenaline in cardiogenic shock is a logical 
consequence of the realisation that maintained peripheral vaso- 
constriction is an undesirable state in shock. Isoprenaline 
increases heart rate and cardiac index and causes peripheral 
vasodilatation (110) (140) and the drug is obviously suitable 
for the operation of a low pressure -high flow state in cardio- 
genic shock. It warrants further clinical trials since there 
is/ 
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is, as yet, little reported clinical experience with the drug. 
In dogs the (.3 effect on the heart was not maintained with 
prolonged infusions (85) but this does not seem to be the case 
in man. A suggestion that the drug may precipitate arrhyth- 
mias (136) has not been borne out (110). 
Adrenergic Blocking Drugs 
/3 blocking drugs are not recommended in cardiogenic 
shock since they block inotropic action on the heart and lead 
to a fall in cardiac index (95) (136). 
0( blocking agents such as phenoxybenzanine or 
chlorpromazine (36) provide a suitable alternative to the use 
of ' drugs. As previously described prolonged reduction of 
perfusion in the peripheral circulation may lead to several 
potentially lethal changes (14) and although noradrenaline 
may initially elevate cardiac index and blood pressure 
eventually it causes a fall in cardiac index while the blood 
pressure remains elevated in a high pressure -low flow system. 
However, low pressures may give an adequate flow provided 
vasoconstriction caused by circulating catecholamines and 
nervous activity is reduced or overcome. Pressure may have 
to be maintained at 50 - 80 mm.Hg. to maintain adequate 
coronary and cerebral blood flow although it is probable that 
in cases with grossly diseased arteries these pressures may 
not be adequate enough. This is one of the problems. In 
general, however, low pressures, when associated with vaso- 
dilatation, are compatible with prolonged survival if fluid 
balance is maintained and the patient is positioned to 
facilitate cerebral perfusion and venous return (this applies 
also to ' drug therapy.) 
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The logic of N blocking is that vasoconstriction will 
be reduced, resistance will fall, capacitance will rise and 
the reduction in pressure will mean less pressure work for, 
and a lower myocardial oxygen consumption by, the heart. 
The fall in resistance will lead to increased cardiac empty- 
ing and the increased capacitance may be useful in the treat- 
ment of pulmonary oedema (14). 
So far, this approach to therapy has been established 
mainly in dogs (12) (14) (35) (36) (90) and awaits controlled 
application to human cardiogenic shock (18) (87). Dog ex- 
periments have their limitations but in view of the failure 
of classical vasoconstrictor therapy this treatment invites 
application. In dogs with shock phenoxybenzamine plus intra- 
venous fluid or phenoxybenzamine plus intravenous fluid plus 
noradrenaline leads to very significant increased survival 
from cardiogenic shock (12) (35) (36) as compared with con- 
trols or noradrenaline treated animals. In general, sur- 
vival is improved when the pressure work of the heart is de- 
creased and the volume work is increased (34). The technique 
has also been successful in patients with low -output surgical 
shock (12) (35). When using this form of therapy it is 
desirable to keep the central venous pressure at 10 - 12 mm.H20 
with careful monitoring and infusion of fluid when required. 
Monitoring of pulmonary arterial pressure has been suggested 
as a more reliable indicator of impending pulmonary oedema 
(61). Dietzman (36) recommends plasma or low molecular 
weight dextran as the fluids of choice for administration. 
The success of intravenous infusions of 5iß dextrose alone has 
been noted by one investigator (114) (114a) and it has been 
suggested/ 
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suggested that in some cases the injured ventricle can still 
operate on the ascending portion of its Starling curve in 
response to distension (16) (127). 
Low Molecular Weight Dextran (L.M.W.D.) 
The properties of L.M.W.D. are complex but consist 
basically of a reduction in the viscosity of the blood (8) 
(13) (91), an increase in the circulating blood volume and 
the activation of fibrinolysis (13). Its properties are 
such as to make it useful in the shock state particularly 
in view of the suggested importance of disseminated intra- 
vascular coagulation (60) (61) or sludging in the pathogenesis 
of shock. Block (12) (13) has found that treatment with 
L.M.W.D. alone in experimental cardiogenic shock in dogs 
significantly improves survival as compared with control un- 
treated dogs. The same group of workers have also used 
L.M.W.D. with favourable results in low -output surgical shock 
(36). 
In a situation where the cardiopulmonary system is fail- 
ing to supply enough oxygen to the tissues logical therapy 
would attempt to increase the supply of oxygen or decrease 
the demand. Hypothermia is one way of decreasing demand (17). 
Hypothermia 
Reduction of body temperature to 33 °C reduces oxygen 
consumption to i normal and reduction to 30 °C reduces it to 
normal. The technique has been used successfully in the 
treatment of septic shock (11) where patients not responding 
to conventional therapy were cooled by surface contact with 
a refrigerated rubber blanket to 32 °C and progressed to a 
50% survival. Shivering is a complication which raises the 
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oxygen consumption but this can be controlled by neuro- 
muscular blocks (10). At moderate temperatures (32 °C) 
myocardial efficiency is enhanced and ventilation is aug- 
mented. Blood chemistry is not dangerously altered at 
32°C (10). The only suggested danger is an increased risk 
of arrhythmias (10) which is particularly inappropriate in 
myocardial infarction. The healing of the infarct will 
also be delayed. This form of therapy would seem to be 
worth a trial at least in animals. It may be necessary to 
counteract to some extent the vasoconstriction associated 
with hypothermia to achieve maximal benefit from this therapy. 
One way of increasing the supply of oxygen to the body 
is by hyperbaric oxygen therapy. 
Hyperbaric Oxygen 
At 3 atmospheres of 100% 02 the pulmonary capillary 
blood should contain 6.8 m1.02 /100 ml. blood in solution. 
In fact, for a variety of reasons (129), it only contains 
ti 5 m1.02 /100 ml. blood in solution as compared with 0.31 ml. 
02/100 ml. blood at one atmosphere of air. This represents 
an increase of 25% in the total amount of oxygen carried by 
the blood and the accompanying high partial pressure 
(1700 mm.Hg.) greatly increases the gradient and hence 
diffusion from the blood to the tissues (129) (136). In 
dogs hyperbaric oxygen protects against death due to ven- 
tricular fibrillation after embolisation (84) or coronary 
artery ligation (159) and may decrease the size of the infarct 
(84). The protection increases with increasing pressures 
(28) (47). In dogs also hyperbaric oxygen improves sur- 
vival after diffuse myocardial infarction (74). In pigs 
(coronary/ 
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(coronary circulation similar to human) 1.25 atmospheres of 
100% 02 increase survival after coronary occlusion by aneroid 
constrictor (120). In man, the haemodynamic effects are an 
exaggeration of those observed in conventional oxygen therapy 
(24) (38) and oxygen toxicity (39) does not yet seem to have 
been a problem. In acute myocardial infarction with and 
without shock hyperbaric oxygen therapy has no effect on 
mortality although acidosis is reversed and there is a non - 
statistical suggestion of a reduction in the number of 
arrhythmias (24). There is a suggestion that failure of 
therapy in cardiogenic shock may be related to technical 
problems of managing decompression during the therapy (22). 
The type of mask is important (22). Cameron (23) presents 
an interesting case of cardiogenic shock where 100% 02 at 
two atmospheres failed to raise Pa02 above 180 mmHg. This 
probably indicates the presence of a considerable shunt 
(cf. (96)). 
When some of the technical difficulties have been over- 
come (22) (129) it may be possible to estimate more accurately 
the importance of this form of therapy for the future. 
Two more drugs merit brief mention. 
Digitalis 
Digitalis is recommended for the treatment of left ven- 
tricular failure in cardiogenic shock (55) (130) (136). 
MacKenzie's suggestion that the inability of digitalis to 
increase cardiac output in shocked patients (97) is related 
to the metabolic acidosis invites further examination. The 
danger of arrhythmias may be greater in the infarcted heart 
(75) (136). Nevertheless, the benefits of the drug probably 
outweigh/ 
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outweigh this disadvantage. 
Hydrocortisone 
This drug has been given a control trial and seemed to 
have no significant beneficial effect in cardiogenic shock 
(132). More recently, however, the use of massive doses 
of glucocorticoids (30 mg /Kg. methyl prednisolone, 150 mg/ 
Kg. hydrocortisone sodium succinate) has been successful in 
experimental cardiogenic shock in dogs and in low- output 
surgical shock in man (37). The glucocorticoids decrease 
peripheral resistance by an unknown mechanism and it is 
suggested that they may help to maintain the integrity of 
cell membranes and sub- cellular particles such as lysosomes 
(37). 
The use of such large doses in cardiogenic shock proper 
is not yet recorded and may prove to be beneficial. 
Although in some patients the therapy which has been 
outlined so far may be of value, in others the impairment of 
cardiac function and its consequences will be too severe to 
be resolved by administration of the appropriate drugs, 
oxygen etc.. For these cases the hope must lie in the future 
in the possibility of some sort of assisted circulation used 
in association with vasodilator therapy - or in the trans- 
plantation of real and artificial hearts. 
Assisted Circulation 
Among the numerous bypass techniques and artificial 
devices which have been used to assist the circulation are 
the following: - 
1. Veno- arterial shunts - in which blood from the venous 
side of the circulation is asynchronously pumped to 
the/ 
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the femoral artery (27) (144). This has not been 
successful since the heart is ejecting against the 
pressure of the bypass pump and myocardial oxygen 
consumption is increased. If an oxygenator is 
used the blood is liable to haemolysis. 
2. Left- atrial to femoral bypass (27) (33). Left ven- 
tricular work and oxygen consumption are only reduced 
when an almost complete bypass is used and a simple 
technique has yet to be perfected (33). 
3. Synchronous assistance or diastolic augmentation 
by (a) Counterpulsation. This procedure involves 
cannulation of the femoral artery and the 
withdrawal of blood during systole which 
is pumped back during diastole. This 
markedly reduces systolic pressure and 
increases diastolic pressure with sub- 
sequent beneficial effects on myocardial 
oxygen consumption and coronary blood flow 
(27) (142). Proper phasing is essential 
(142). Embolised dogs have a 40% greater 
survival after counterpulsation (71). The 
technique is now being tried on patients 
with a 30 hour history of cardiogenic 
shock and refractoriness to noradrenaline 
therapy (144). So far there is one sur- 
vivor out of seven very old patients. 
Three others showed transitory improvement 
in their condition. The withdrawal of 
blood by the pump was limited by the dis- 
eased state of their vessels. 
It/ 
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It seems that the effect on coronary blood 
flow may be retained some time after the 
procedure is terminated (144). The ad- 
vantages of this technique are that no 
massive surgery is needed and that blood 
haemolysis does not seem to be a problem. 
The difficulty of phasing the pump is a 
disadvantage. 
(b) Synchronous external assistance, (116) (143) 
effectively uses the vascular tree of the 
lower limbs or body as the pump in counter - 
pulsation. The lower limbs are enclosed 
in a pressure suit or chamber and subjected 
to appropriately phased pressure variations. 
So the technique has been used only on 
animals but as it is atraumatic it holds 
promise for the future. 
4. Implantable prosthesis. The notable developments in 
this field have been in the in- series, air -powered, 
prosthetic auxiliary ventricles of Soroff (9) (49) 
(92) and Kantrowitz (26). In the infarcted dog heart 
these reduced the pressure work of the heart by 47%, 
rendered the elevated right atrial pressure to normal 
and produced a 4051, increase in coronary blood flow 
and a 54% increase in aortic outflow (26). This de- 
vice has been tried on two patients with severe con- 
gestive heart failure (76). One patient died within 
24 hours but the other responded favourably before 
dying from a cerebrovascular accident 10 days after 
the/ 
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the operation. A considerable amount of clotting 
was present on the prosthesis post mortem and this 
led to further modifications in design (76). The 
solution of the clotting problem would be a major 
advance in this field. The prosthesis may ul- 
timately be of use in cardiogenic shock. 
5. Artificial intracorporeal hearts. Twenty -six 
different mechanical hearts have been reported since 
1958 (68). Most of them are air -driven and so far 
no animal has survived more than 30 hours with a 
functioning artificial heart. A haemodynamically 
sound heart has not yet been produced and the prob- 
lems still remain those of clotting, haemolysis (3) 
(48) (56) and unbalanced perfusion (4). With 
further development and research the artificial 
heart may become a real prospect for the therapy 
of cardiogenic shock. Indeed, World Health 
Organisation has gone so far as to prophesy heart 
factories for the future in a recent report. 
For the moment, however, attention is directed 
towards another surgical procedure namely that of 
cardiac transplantation. 
Cardiac Transplantation 
Surgical technique is not the limiting factor in cardiac 
transplantation (41) since autograft transplants have sur- 
vived for up to two years (40). The limiting factors with 
homograft transplantation are tissue typing (108), the graft 
vs. host reaction, catecholamine hypersensitivity (41), the 
homograft rejection phenomenon, its detection (108) and 
control/ 
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control with immuno- suppressive therapy (109). In dogs 
homograft transplants have survived 1 to 3 months with 
intermittent immuno- suppressive therapy (93) and at the 
time of writing Dr. Blaiberg is nearing the end of his 
third month with a transplanted heart. The problem of 
preserving the heart between donor and host seems recently 
to have been resolved by the use of hyperbaric oxygen and 
hypothermia which may preserve the heart for 48 hours with 
complete return to function. The possibility of heart 
banks is now being considered but such a development must 
await the solution of the many other technical problems 
involved in transplantation before it will bear full fruit. 
Moreover, transplantation of the heart raises many 
interesting ethical and social problems (122) which have 
yet to be resolved. More particularly the definition of 
death requires a long awaited modification and this problem 
is now to be considered by the British Medical Association 
(19). Whether the development of a successful artificial 
heart will precede the breakthrough in the problems of 
cardiac homograft transplantation remains to be seen. 
Meanwhile, there is adequate time to consider the implications 
of either (122). 
SUMMARY AND CONCLUSIONS 
The difficulties of defining cardiogenic shock have been 
discussed in the text. 
The immediate and obvious lesion in myocardial infarction 
is a damaged heart and haemodynamic studies indicate that the 
mechanical function of the heart is most severely damaged in 
those patients who develop cardiogenic shock (96) (162). 
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The consequences of impaired cardiac function are twofold. 
Firstly, the fall in cardiac index ( "forward failure ") 
(148) (162) means that the heart is unable to maintain blood 
pressure and to supply all the tissues adequately with oxy- 
genated blood. The sympatho- adrenal response effects a 
redistribution of blood flow which favours the coronary and 
cerebral circulations although the coronary flow is likely 
to be pressure dependent (54) (63) (127) and therefore still 
in danger. The reduction in tissue blood flow in general 
(due to vasoconstriction and decreased cardiac index) leads 
to tissue hypoxia as indicated by the rise in the lactate/ 
pyruvate ratio (96). All tissues are affected by the hypoxia 
but some probably more than others. In the kidney, e.g., 
structural changes may be seen eventually (156) whereas 
functional changes are described e.g., liver (21). 
The higher incidence of arrhythmias and asystole in cardio- 
genic shock compared with uncomplicated myocardial infarction 
is probably a reflection of the hypoxic state of cardiac 
muscle (50) (80). 
Secondly, the heart is unable to cope with the load 
placed upon it and pressures rise behind the left ventricle 
(82) with resultant pulmonary congestion (87) (101) and im- 
paired lung function (65) (101) (117) ( "backward failure ") 
which leads to further hypoxaemia and exaggerates the tissue 
hypoxia. 
The state of reduced flow and tissue hypoxia leads to 
a progression of events involving the development of hypo- 
tension, refractoriness to noradrenaline, microcirculatory 
defects, coagulation defects, capillary damage, haemo- 
concentration/ 
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haemoconcentration, metabolic changes and, ultimately, 
tissue and bodily death. 
The therapy of shock should be determined by the in- 
dividual characteristics of each case taking into account 
the severity of shock, length of time in shock and various 
complicating factors such as pulmonary oedema and arrhythmias 
(124) (130). The aim should be to improve or assist cardiac 
performance. 
Initially, there was belief in the adequacy of administer 
ing noradrenaline and elevating blood pressure in therapy of 
shock but with fuller understanding of the pathogenesis of 
shock and the haemodynamic consequences of administering nor- 
adrenaline the general failure of noradrenaline therapy is 
understandable. For the few patients who are responsive to 
inotropic doses of noradrenaline there is no problem. For 
the majority there is no adequate therapy and it ill befits 
the physician to send his patient to the grave with ever in- 
creasing doses of noradrenaline. 
The logical arguments for hypothermia and hyperbaric 
oxygen therapy invite their further controlled application. 
However, it would seem that some immediate hope may lie in 
"vasodilator therapy ". ('block or drug + L.M.W.D.). 
Low molecular weight dextran is probably useful in treating 
the coagulation which may be seen in shock. The infusion of 
5;5 dextran alone as standard therapy for cardiogenic shock 
(114) (114a) is not recommended since most cases of shock 
have evidence of pulmonary congestion and it is unlikely that 
the heart is operating on the ascending portion of its Star- 
ling curve. If, as will probably be the case, the main- 
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maintenance of adequate pressure and flow with vasodilator 
therapy is only possible in a small percentage of cases then 
this form of therapy could be combined with a form of assisted 
circulation. The relative simplicity of external and in- 
ternal counterpulsation recommends them but it may be that 
when the clotting problems of the auxiliary ventricle have 
been overcome that it will occupy an important place in the 
therapy of cardiogenic shock. Some patients will need only 
temporary assistance until cardiac function improves but 
others will need permanent assistance and there is scope for 
much development in this field. 
Ultimately, in this increasingly material- orientated 
world the possibility of intracorporeal hearts for all will 
have to be considered. The difficulties attaching to cardiac 
transplantation may not be fully resolved before the artificial 
heart is perfected. In any case, if this line of therapy is 
exploited for the treatment of cardiogenic shock or any other 
disease certain moral and social problems remain to be re- 
solved. 
At the moment it is probably not inaccurate to describe 
cardiogenic shock as "a momentary pause in the act of dying" 
(163). The present essay has tried to indicate the reason 
for this state of affairs and to outline the course which 
advances in therapy may take to remedy it. 
ADDENDUM. 
The inotropic action of paired pulse stimulation. 
Since completing this essay the details of some 
work concerning the above have been published. 
The paper confirms the inotropic action of 
paired pulse stimulation in the normal dog heart. In 
dogs with myocardial damage, however, although paired 
pulse stimulation produced an initial inotropic effect, 
after 30 minutes there was evidence of more marked 
left ventricular failure than was present initially. 
The damaged ventricle recovered its original function 
on reverting to single pulse stimulation. 
The authors suggest from the evidence available 
that the increased myocardial oxygen requirements with 
paired pulse stimulation cannot be met by an appropriate 
increase in coronary blood flow to the damaged left 
ventricle. 
It would seem from this study that paired pulse 
stimulation is not the answer to the problem of 
improving the function of the infarcted and failing 
heart. 
Reference: King, A.J. and Taylor, D.E..: 
The inotropic action of paired pulse 
stimulation in the normal and failing 
heart: an experimental study. 
Cardiovasc. Res. 2: 122 -129 (1968) 
APPENDIX. 
1. The studies of Mellander & Lewis. (89) (107). 
The preparation consisted of the hind part of a 
cat isolated from the fore part leaving only the 
abdominalaorta, the inferior vena cava and the lumbar 
sympathetic nerves intact. The skin was removed in 
some animals to give a "pure muscle" preparation. 
Some animals were eviscerated. Arterial pressure 
was measured in the inferior mesenteric artery; 
venous outflow by a drop recorder in the inferior 
vena cava and volume changes of the lower limbs by 
a water filled, temperature regulated plethysmograph. 
The lumbar sympathetic trunks were sectioned at mid 
abdominal level and stimulated at supramaximal voltage 
ar 3 m.sec. duration within the range of 1 -20 impulses/ 
sec. Haemorrhagic hypotension was induced by bleeding 
the animal until the blood pressure stabilised at 
40 -50 mm. Hg. 
For further details of experiment and analysis 
see Mellander, S. : Comparative studies 
on the adrenergic neurohormonal control 
of resistance and capacitance blood vessels 
in the cat. 
Acta. Physiol.Scand.50: 
Supp1.176: 1.(1960) 
Figs. 1 and 2 are taken from ref. (89) and are 
referred to in the text. 
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FIGURE 2 
Reactivity Of resistance and capacitance vessels to vasoconstrictor fiber stimulation 
(2 imp /.e'). Data tabn Prou, ex». shown in figure 1. Note the much more rapid decline 
in the re.si.stam, response than iI, the capacitance response during the period of 
hemorrhagic shock. Bolli re..pnnses recorered to about normal when the shed _blood 
was returned. 
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